Gi-Hoon Nam, the co-founder and Chief Scientific Officer (CSO) of SHIFTBIO Inc, presented as a panelist at the 23rd World Knowledge Forum (WKF) on September 22nd. In the session of 'New Drug Development: How is New Drug Development Possible.' The other renowned bio-industry leaders also participated as panelists, including Mordechai Sheves, a Vice President of Technology Transfer at Weizmann Institute of Science, Chairman of Yeda LTD; Woong-Yang Park, CEO of Geninus Inc; Sang-Hoon Lee, CEO of ABL Bio Inc; and Cherry Chen Huang, the Area Managing Director of Janssen North Asia.
The World Knowledge Forum is the biggest knowledge-sharing event in the world. The 23rd WKF has held from September 20th to September 22nd at Shilla Hotel, Seoul, Korea.
You can reach out to the full content through the link below: